CENTOGENE, N.V. (CNTG): שווי מצרפי של הפעילות העסקית

Centogene N.V. is developing digital biodata processing systems for the rapid identification of rare pathologies, while the current market quotes visualized below reflect an Enterprise Value of . Business growth is driven by a staff of leading bioinformaticians attracted by the uniqueness of the scientific archives. However, the high cost of technology maintenance and pressure from industry behemoths pose a threat of reducing the company's market influence.

The monolithic defensive moat of Centogene N.V., based on a unique bank of rare mutations, makes the enterprise value a key indicator for assessing this tech asset. The current is calculated as the sum of market capitalization and net debt, allowing investors to determine the actual buyout price of the business by eliminating emotional price volatility and assessing the risk of overpayment.